Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Security class unavailable · CUSIP: 61225M102
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,146,919
- Percent of class
- 8.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-22-000962
- Form type
- SC 13G
- Filer
- Monte Rosa Therapeutics, Inc.
- CIK
- CIK 1826457
- Filed
- Feb 10, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership